Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin P Annes

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Nature Metabolism|October 15, 2024
Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenaseShane M O'Carroll, Christian G Peace, Juliana E Toller-Kawahisa, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetesShiva Pathak, Rizwan Ahmed, Nadine Nagy, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Nature Metabolism|October 15, 2024
Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenaseShane M O'Carroll, Christian G Peace, Juliana E Toller-Kawahisa, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetesShiva Pathak, Rizwan Ahmed, Nadine Nagy, et al.
Pageof 5